November 10, 2023
BeneCard PBF monitors the industry, as well as government regulations, for areas that may have an influence on
prescription benefits and compliance. Our goal is to help our clients continue to exceed their benefit
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
News
November 10, 2023
November 10, 2023 - Valneva SE, a specialty vaccine company, has announced that the U.S. Food and Drug
Administration (FDA) has approved Ixchiq®. Valneva’s single-dose
November 9, 2023
November 9, 2023 - For patients undergoing open lumbar laminectomy, ultrasound-guided bilateral
erector spinae plane blocks (ESPBs) combined with multimodal analgesia reduce
November 9, 2023
November 9, 2023 - Earlier onset of atrial fibrillation (AF) is associated with increased risk of developing
all-cause dementia, vascular dementia (VD), and Alzheimer disease (AD), according to a study
November 8, 2023
November 8, 2023 - Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved FruzaqlaTM (fruquintinib), an oral targeted therapy for adults with metastatic
November 8, 2023
November 8, 2023 - The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's
ZepboundTM (tirzepatide) injection, the first and only obesity treatment
November 6, 2023
November 06, 2023 - Zydus Lifesciences Limited has announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application
November 1, 2023
November 1, 2023 - The Food and Drug Administration (FDA) is advising healthcare providers who
administer the Moderna COVID-19 Vaccine (2023-2024 Formula)